Evidence map›Paper›PMID 32493785›Full record

ArticleJournal of clinical microbiology2020

Expert Opinion on Verification of Antimicrobial Susceptibility Tests.

Jean B Patel, Richard B Thomson, Kevin Alby, Esther Babady, Karissa Culbreath, Marcelo F Galas, Shawn R Lockhart, Brian V Lubbers, Margie Morgan, Sandra S Richter and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jean B PatelBeckman Coulter Microbiology, West Sacramento, California, USA jbpatel@beckman.com.
Richard B ThomsonNorthshore University Health System, Evanston, Illinois, USA.
Kevin AlbyUniversity of North Carolina Health, Chapel Hill, North Carolina, USA.ORCID 0000-0003-4637-8474
Esther BabadyMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-4399-1249
Karissa CulbreathTriCore Reference Laboratories, Albuquerque, New Mexico, USA.
Marcelo F GalasPan American Health Organization, Washington, DC, USA.
Shawn R LockhartCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Brian V LubbersKansas State University, Manhattan, Kansas, USA.
Margie MorganCedars-Sinai Medical Center, Los Angeles, California, USA.
Sandra S RichterbioMerieux, Durham, North Carolina, USA.
Susan SharpCopan Diagnostics, Murrieta, California, USA.
Ribhi M ShawarU.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Ana Maria CardenasBD Diagnostics, Sparks, Maryland, USA.
German EsparzaProasecal LTD, Bogotá, Colombia.
Nicole HubbardLMC Pathology Services, Valley Health System, Las Vegas, Nevada, USA.
Mark G PapichNorth Carolina State University, Raleigh, North Carolina, USA.
Audrey N SchuetzMayo Clinic, Rochester, Minnesota, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsPseudomonas InfectionsAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAnti-Infective Agentsantibioticantifungal susceptibility testingantimicrobialCLIAverification

Identifiers

PMID32493785
PMCPMC7587095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.